Developmental neuroplasticity and the origin of neurodegenerative diseases

World Journal of Biological Psychiatry

Volumn 17, Issue 8, 2016, Pages 587-599

  Schaefers, Andrea T U ^a   Teuchert Noodt, Gertraud ^a  

^a BIELEFELD UNIVERSITY   (Germany)

Author keywords

Alzheimer's disease; brain development; Neurodegenerative diseases; neuroplasticity; Parkinson's disease

Indexed keywords

ALPHA SYNUCLEIN; AMYLOID BETA PROTEIN; PSYCHOTROPIC AGENT;

ADULTHOOD; AGING; BRAIN REGION; DEGENERATIVE DISEASE; EARLY LIFE STRESS; ENVIRONMENTAL FACTOR; HEAVY METAL POISONING; HIPPOCAMPUS; HUMAN; NERVE CELL DIFFERENTIATION; NERVE CELL PLASTICITY; NERVE DEGENERATION; NERVOUS SYSTEM DEVELOPMENT; NEUROFIBRILLARY TANGLE; NONHUMAN; REVIEW; RISK FACTOR; ALZHEIMER DISEASE; GROWTH, DEVELOPMENT AND AGING; METABOLISM; PARKINSON DISEASE; PATHOPHYSIOLOGY; PHYSIOLOGY;

AGING; ALZHEIMER DISEASE; AMYLOID BETA-PEPTIDES; HIPPOCAMPUS; HUMANS; NEURONAL PLASTICITY; PARKINSON DISEASE;

EID: 84994480414     PISSN: 15622975     EISSN: 18141412     Source Type: Journal    
DOI: 10.3109/15622975.2013.797104     Document Type: Review

References (181)

1. M.F.Allam, A.S.Del Castillo, R.F.Navajas. 2005. Parkinson's disease risk factors:genetic, environmental, or both? Neurol Res 27:206–208.
2. K.D.Alex, G.J.Yavanian, H.G.McFarlane, C.P.Pluto, E.A.Pehek. 2005. Modulation of dopamine release by striatal 5-HT2C receptors. Synapse 55:242–251.
3. A.Al-Wandi, N.Ninkina, S.Millership, S.J.Williamson, P.A.Jones, V.L.Buchman. 2010. Absence of alpha-synuclein affects dopamine metabolism and synaptic markers in the striatum of aging mice. Neurobiol Aging 31:796–804.
4. D.Amaral, P.Lavanex. 2006. Hippocampal neuroanatomy. In:P.Andersen, R.Morris, D.Amaral, T.Bliss, J.O'Keefe, editors. The hippocampus book. Oxford:Oxford University Press. p. 37–114.
5. D.G.Amaral, M.P.Witter. 1995. Hippocampal Formation. In:G.Paxinos, editor. The rat nervous system. Sydney:Academic Press. p. 443–493.
6. S.L.Andersen. 2003. Trajectories of brain development:point of vulnerability or window of opportunity? Neurosci Biobehav Rev 27:3–18.
7. T.Archer. 2010. Neurodegeneration in schizophrenia. Expert Rev Neurother 10:1131–1141.
8. T.Arendt. 2001a. Alzheimer's disease as a disorder of mechanisms underlying structural brain self-organization. Neuroscience 102:723–765.
9. T.Arendt. 2001b. Disturbance of neuronal plasticity is a critical pathogenetic event in Alzheimer's disease. Int J Dev Neurosci 19:231–245.
10. T.Arendt. 2004. Neurodegeneration and plasticity. Int J Dev Neurosci 22:507–514.
11. T.Arendt, M.K.Bruckner, H.J.Gertz, L.Marcova. 1998. Cortical distribution of neurofibrillary tangles in Alzheimer's disease matches the pattern of neurons that retain their capacity of plastic remodelling in the adult brain. Neuroscience 83: 991–1002.
12. T.Arendt, J.Stieler, A.M.Strijkstra, R.A.Hut, J.Rudiger, E.A.Van der Zee,. 2003. Reversible paired helical filament-like phosphorylation of tau is an adaptive process associated with neuronal plasticity in hibernating animals. J Neurosci 23: 6972–6981.
13. B.Artaso-Irigoyen, A.Goñi-Sarriés, A.R.Gómez-Martínez. 2004. [Neuropsychiatric symptoms in dementia syndrome]. Rev Neurol 38:506–510.
14. V.Bagetta, V.Ghiglieri, C.Sgobio, P.Calabresi, B.Picconi. 2010. Synaptic dysfunction in Parkinson's disease. Biochem Soc Trans 38:493–497.
15. F.Bagorda, G.Teuchert-Noodt, K.Lehmann. 2006. Isolation rearing or methamphetamine traumatisation induce a “dysconnection” of prefrontal efferents in gerbils:implications for schizophrenia. J Neural Transm 113:365–379.
16. A.Baudin, K.Blot, C.Verney, L.Estevez, J.Santa-Maria, P.Gressens,. 2012. Maternal deprivation induces deficits in temporal memory and cognitive flexibility and exaggerates synaptic plasticity in the rat medial prefrontal cortex. Neurobiol Learn Mem 98:207–214.
17. S.Bellani, V.L.Sousa, G.Ronzitti, F.Valtorta, J.Meldolesi, E.Chieregatti. 2010. The regulation of synaptic function by alpha-synuclein. Commun Integr Biol 3:106–109.
18. E.Bertrand, W.Lechowicz, E.Lewandowska, G.M.Szpak, J.Dymecki, E.Kosno-Kruszewska, T.Wierzba-Bobrowicz. 2003. Degenerative axonal changes in the hippocampus and amygdala in Parkinson's disease. Folia Neuropathol 41:197–207.
19. L.Bidzan. 2006. [Stressful events in childhood and psychiatric disorders in the elderly]. Psychiatr Pol 40:129–138.
20. B.Bingol, M.Sheng. 2011. Deconstruction for reconstruction:the role of proteolysis in neural plasticity and disease. Neuron 69:22–32.
21. J.L.Bizon, M.Gallagher. 2003. Production of new cells in the rat dentate gyrus over the lifespan:relation to cognitive decline. Eur J Neurosci 18:215–219.
22. W.Birkmayer, P.Riederer. 1986. Neurotransmitter und menschliches Verhalten. Berlin, Heidelberg, New York Tokyo:Springer.
23. B.Blaesing, M.Nossoll, G.Teuchert-Noodt, R.R.Dawirs. 2001. Postnatal maturation of prefrontal pyramidal neurones is sensitive to a single early dose of methamphetamine in gerbils (Meriones unguiculatus). J Neural Transm 108:101–113.
24. A.R.Borenstein, C.I.Copenhaver, J.A.Mortimer. 2006. Early-life risk factors for Alzheimer disease. Alzheimer Dis Assoc Disord 20:63–72.
25. N.M.Bosch, H.Riese, S.A.Reijneveld, M.P.Bakker, F.C.Verhulst, J.Ormel, A.J.Oldehinkel. 2012. Timing matters:Long term effects of adversities from prenatal period up to adolescence on adolescents’ cortisol stress response. The TRAILS study. Psychoneuroendocrinology 37:1439–1447.
26. H.Braak, E.Ghebremedhin, U.Rub, H.Bratzke, T.K.Del. 2004. Stages in the development of Parkinson's disease-related pathology. Cell Tissue Res 318:121–134.
27. H.Braak, J.R.Bohl, C.M.Muller, U.Rub, R.A.de Vos, T.K.Del. 2006. Stanley Fahn Lecture 2005:The staging procedure for the inclusion body pathology associated with sporadic Parkinson's disease reconsidered. Mov Disord 21:2042–2051.
28. R.Brookmeyer, S.Gray. 2000. Methods for projecting the incidence and prevalence of chronic diseases in aging populations:application to Alzheimer's disease. Stat Med 19:1481–1493.
29. S.Brummelte, G.Teuchert-Noodt. 2006. Postnatal development of dopamine innervation in the amygdala and the entorhinal cortex of the gerbil (Meriones unguiculatus). Brain Res 1125: 9–16.
30. S.Brummelte, G.Teuchert-Noodt. 2007. Density of dopaminergic fibres in the prefrontal cortex of gerbils is sensitive to aging. Behav Brain Funct 3:14.
31. S.Brummelte, T.Grund, A.Czok, G.Teuchert-Noodt, J.Neddens. 2006. Long-term effects of a single adult methamphetamine challenge:minor impact on dopamine fibre density in limbic brain areas of gerbils. Behav Brain Funct 2:12.
32. S.Brummelte, J.Neddens, G.Teuchert-Noodt. 2007. Alteration in the GABAergic network of the prefrontal cortex in a potential animal model of psychosis. J Neural Transm 114:539–547.
33. J.Bu, V.Sathyendra, N.Nagykery, C.Geula. 2003. Age-related changes in calbindin-D28k, calretinin, and parvalbumin- immunoreactive neurons in the human cerebral cortex. Exp Neurol 182:220–231.
34. A.Busche, J.Neddens, C.Dinter, R.R.Dawirs, G.Teuchert-Noodt. 2002. Differential influence of rearing conditions and methamphetamine on serotonin fibre maturation in the dentate gyrus of gerbils (Meriones unguiculatus). Dev Neurosci 24: 512–521.
35. A.Busche, D.Polascheck, J.Lesting, J.Neddens, G.Teuchert- Noodt. 2004. Developmentally induced imbalance of dopaminergic fibre densities in limbic brain regions of gerbils (Meriones unguiculatus). J Neural Transm 111:451–463.
36. A.Busche, A.Bagorda, K.Lehmann, J.Neddens, G.Teuchert- Noodt. 2006. The maturation of the acetylcholine system in the dentate gyrus of gerbils (Meriones unguiculatus) is affected by epigenetic factors. J Neural Transm 113:113–124.
37. M.Butz, G.Teuchert-Noodt, K.Grafen, O.A.van. 2008. Inverse relationship between adult hippocampal cell proliferation and synaptic rewiring in the dentate gyrus. Hippocampus 18: 879–898.
38. C.Caldji, J.Diorio, M.J.Meaney. 2003. Variations in maternal care alter GABA(A) receptor subunit expression in brain regions associated with fear. Neuropsychopharmacology 28: 1950–1959.
39. H.A.Cameron, R.D.McKay. 1999. Restoring production of hippocampal neurons in old age. Nat Neurosci 2:894–897.
40. J.Campdelacreu. 2012. Parkinson disease and Alzheimer disease:environmental risk factors. Neurologia [Epub ahead of print].
41. T.D.Cannon, T.G.van Erp, R.Loewy, F.Thompson, A.W.Toga, M.O.Huttunen. 2003. Early and late neurodevelop mental influences in the prodrome to schizophrenia:contributions of genes, environment, and their interactions. Schizophr Bull 29:653–669.
42. G.A.Carlesimo, F.Piras, F.Assogna, F.E.Pontieri, C.Caltagirone, G.Spalletta. 2012. Hippocampal abnormalities and memory deficits in Parkinson disease:a multimodal imaging study. Neurology 78:1939–1945.
43. H.Chen, S.M.Zhang, M.A.Schwarzschild, M.A.Hernan, A.Ascherio. 2005. Physical activity and the risk of Parkinson disease. Neurology 64:664–669.
44. F.Cheng, X.Li, Y.Li, C.Wang, T.Wang, G.Liu,. 2011. Alpha-Synuclein promotes clathrin-mediated NMDA receptor endocytosis and attenuates NMDA-induced dopaminergic cell death. J Neurochem 119:815–825.
45. D.F.Clayton, J.M.George. 1998. The synucleins:a family of proteins involved in synaptic function, plasticity, neurodegeneration and disease. Trends Neurosci 21:249–254.
46. D.F.Clayton, J.M.George. 1999. Synucleins in synaptic plasticity and neurodegenerative disorders. J Neurosci Res 58:120–129.
47. U.Dannlowski, A.Stuhrmann, V.Beutelmann, P.Zwanzger, T.Lenzen, D.Grotegerd,. 2012. Limbic scars:long-term consequences of childhood maltreatment revealed by functional and structural magnetic resonance imaging. Biol Psychiatry 71:286–293.
48. R.R.Dawirs, G.Teuchert-Noodt. 2001. A novel pharmacological concept in an animal model of psychosis. Acta Psychiatr Scand Suppl 408:10–17.
49. R.R.Dawirs, G.Teuchert-Noodt, R.Czaniera. 1993. Maturation of the dopamine innervation during postnatal development of the prefrontal cortex in gerbils (Meriones unguiculatus). A quanti tative immunocytochemical study. J Hirnforsch 34: 281–290.
50. R.R.Dawirs, G.Teuchert-Noodt, R.Czaniera. 1994. The postnatal maturation of dopamine innervation in the prefrontal cortex of gerbils (Meriones unguiculatus) is sensitive to an early single dose of methamphetamine. A quantitative immunocytochemical study. J Hirnforsch 35:195–204.
51. R.R.Dawirs, K.Hildebrandt, G.Teuchert-Noodt. 1998. Adult treatment with haloperidol increases dentate granule cell proliferation in the gerbil hippocampus. J Neural Transm 105: 317–327.
52. R.R.Dawirs, G.Teuchert-Noodt, K.Hildebrandt, F.Fei. 2000. Granule cell proliferation and axon terminal degradation in the dentate gyrus of gerbils (Meriones unguiculatus) during maturation, adulthood and aging. J Neural Transm 107:639–647.
53. P.Desplats, B.Spencer, L.Crews, P.Pathel, D.Morvinski-Friedmann, K.Kosberg,. 2012. α-Synuclein induces alterations in adult neurogenesis in Parkinson disease models via p53-mediated repression of Notch1. J Biol Chem 287:31691–31702.
54. V.Di Matteo, G.Di Giovanni, M.Pierucci, E.Esposito. 2008. Serotonin control of central dopaminergic function:focus on in vivo microdialysis studies. Prog Brain Res 172:7–44.
55. G.Di Rosa, D.Puzzo, A.Sant'Angelo, F.Trinchese, O.Arancio. 2003. Alpha-synuclein:between synaptic function and dysfunction. Histol Histopathol 18:1257–1266.
56. D.W.Dickson, H.A.Crystal, L.A.Mattiace, D.M.Masur, A.D.Blau, P.Davies,. 1992. Identification of normal and pathological aging in prospectively studied nondemented elderly humans. Neurobiol Aging 13:179–189.
57. J.R.Epp, L.A.Galea. 2009. Hippocampus-dependent strategy choice predicts low levels of cell proliferation in the dentate gyrus. Neurobiol Learn Mem 91:437–446.
58. P.S.Eriksson, E.Perfilieva, T.Bjork-Eriksson, A.M.Alborn, C.Nordborg, D.A.Peterson, F.H.Gage. 1998. Neurogenesis in the adult human hippocampus. Nat Med 4:1313–1317.
59. A.Falluel-Morel, K.Sokolowski, H.M.Sisti, X.Zhou, T.J.Shors, E.Cicco-Bloom. 2007. Developmental mercury exposure elicits acute hippocampal cell death, reductions in neurogenesis, and severe learning deficits during puberty. J Neurochem 103:1968–1981.
60. I.Ferrer, A.Martinez, R.Blanco, E.Dalfó, M.Carmona. 2011. Neuropathology of sporadic Parkinson disease before the appearance of parkinsonism:preclinical Parkinson disease. J Neural Transm 118:821–839.
61. R.P.Friedland, T.Fritsch, K.A.Smyth, E.Koss, A.J.Lerner, C.H.Chen,. 2001. Patients with Alzheimer's disease have reduced activities in midlife compared with healthy control-group members. Proc Natl Acad Sci USA 98:3440–3445.
62. M.E.Gilbert, M.E.Kelly, T.E.Samsam, J.H.Goodman. 2005. Chronic developmental lead exposure reduces neurogenesis in adult rat hippocampus but does not impair spatial learning. Toxicol Sci 86:365–374.
63. G.Giordano, L.G.Costa. 2012. Developmental neurotoxicity:Some old and new issues. ISRN Toxicology 2012:814795.
64. P.S.Goldman-Rakic, R.M.Brown. 1982. Postnatal development of monoamine content and synthesis in the cerebral cortex of rhesus monkeys. Brain Res 256:339–349.
65. T.Gonzalez-Salvador, C.G.Lyketsos, A.Baker, L.Hovanec, C.Roques, J.Brandt, C.Steele. 2000. Quality of life in dementia patients in long-term care. Int J Geriatr Psychiatry 15: 181–189.
66. R.L.Good, R.A.Radcliffe. 2011. Methamphetamine-induced locomotor changes are dependent on age, dose and genotype. Pharmacol Biochem Behav 98:101–111.
67. M.Gralle, S.T.Ferreira. 2007. Structure and functions of the human amyloid precursor protein:the whole is more than the sum of its parts. Prog Neurobiol 82:11–32.
68. J.Grutzendler, N.Kasthuri, W.B.Gan.2002. Long-term dendritic spine stability in the adult cortex. Nature 420:812–816.
69. I.Gureviciene, K.Gurevicius, H.Tanila. 2007. Role of alpha- synuclein in synaptic glutamate release. Neurobiol Dis 28: 83–89.
70. A.J.Harding, E.Stimson, J.M.Henderson, G.M.Halliday. 2002. Clinical correlates of selective pathology in the amygdala of patients with Parkinson's disease. Brain 125:2431–2445.
71. A.Herring, L.Lewejohann, A.L.Panzer, A.Donath, O.Kroll, N.Sachser,. 2011. Preventive and therapeutic types of environmental enrichment counteract beta amyloid pathology by different molecular mechanisms. Neurobiol Dis 42: 530–538.
72. K.Hildebrandt, G.Teuchert-Noodt, R.R.Dawirs. 1999. A single neonatal dose of methamphetamine suppresses dentate granule cell proliferation in adult gerbils which is restored to control values by acute doses of haloperidol. J Neural Transm 106: 549–558.
73. G.E.Hodes, L.Yang, K.J.Van, J.Santollo, T.J.Shors. 2009. Prozac during puberty:distinctive effects on neurogenesis as a function of age and sex. Neuroscience 163:609–617.
74. G.E.Hodes, T.E.Hill-Smith, R.F.Suckow, T.B.Cooper, I.Lucki. 2010. Sex-specific effects of chronic fluoxetine treatment on neuroplasticity and pharmacokinetics in mice. J Pharmacol Exp Ther 332:266–273.
75. H.S.Hoe, Z.Fu, A.Makarova, J.Y.Lee, C.Lu, L.Feng,. 2009. The effects of amyloid precursor protein on postsynaptic composition and activity. J Biol Chem 284: 8495–8506.
76. P.R.Hof, J.H.Morrison. 2004. The aging brain:morphomole cular senescence of cortical circuits. Trends Neurosci 27: 607–613.
77. P.R.Hof, C.V.Mobbs. 2009. Handbook of the neuroscience of aging. 1st ed. London:Academic Press.
78. D.H.Hubel, T.N.Wiesel. 1970. The period of susceptibility to the physiological effects of unilateral eye closure in kittens. J Physiol 206:419–436.
79. P.R.Huttenlocher. 1979. Synaptic density in human frontal cortex – developmental changes and effects of aging. Brain Res 163:195–205.
80. P.R.Huttenlocher, A.S.Dabholkar. 1997. Regional differences in synaptogenesis in human cerebral cortex. J Comp Neurol 387:167–178.
81. R.Insausti, M.T.Herrero, M.P.Witter. 1997. Entorhinal cortex of the rat:cytoarchitectonic subdivisions and the origin and distribution of cortical efferents. Hippocampus. 7:146–183.
82. H.Iso, S.Simoda, T.Matsuyama. 2007. Environmental change during postnatal development alters behaviour, cognitions and neurogenesis of mice. Behav Brain Res 179:90–98.
83. W.J.Jagust, E.C.Mormino. 2011. Lifespan brain activity, beta- amyloid, and Alzheimer's disease. Trends Cogn Sci 15: 520–526.
84. K.A.Jellinger. 2011. Synuclein deposition and non-motor symptoms in Parkinson disease. J Neurol Sci 310:107–111.
85. K.A.Jellinger. 2012. Neuropathology of sporadic Parkinson's disease:evaluation and changes of concepts. Mov Disord 27: 8–30.
86. L.G.Kaiser, N.Schuff, N.Cashdollar, M.W.Weiner. 2005. Age- related glutamate and glutamine concentration changes in normal human brain:1H MR spectroscopy study at 4 T. Neurobiol Aging 26:665–672.
87. A.Kalsbeek, P.Voorn, R.M.Buijs, C.W.Pool, H.B.Uylings. 1988. Development of the dopaminergic innervation in the prefrontal cortex of the rat. J Comp Neurol 269:58–72.
88. F.Kamenetz, T.Tomita, H.Hsieh, G.Seabrook, D.Borchelt, T.Iwatsubo,. 2003. APP processing and synaptic function. Neuron 37:925–937.
89. L.Kananen, I.Surakka, S.Pirkola, J.Suvisaari, J.Lonnqvist, L.Peltonen,. 2010. Childhood adversities are associated with shorter telomere length at adult age both in individuals with an anxiety disorder and controls. PLoS One 5:e10826.
90. G.Keilhoff, G.Grecksch, H.G.Bernstein, T.Roskoden, A.Becker. 2010. Risperidone and haloperidol promote survival of stem cells in the rat hippocampus. Eur Arch Psychiatry Clin Neurosci 260:151–162.
91. A.Keller, F.Bagorda, K.Hildebrandt, G.Teuchert-Noodt. 2000. Effects of enriched and of restricted rearing on both neurogenesis and synaptogenesis in the dentate gyrus of adult gerbils (Meriones unguiculatus). Neurol Psychiatry Brain Res 8:101–108.
92. M.I.Khairallah, L.A.Kassem. 2011. Alzheimer's disease:current status of etiopathogenesis and therapeutic strategies. Pak J Biol Sci 144:257–272.
93. W.C.Koller. 1992. When does Parkinson's disease begin? Neurology 42:27–31.
94. D.K.Lahiri, N.H.Zawia, N.H.Greig, K.Sambamurti, B.Maloney. 2008. Early-life events may trigger biochemical pathways for Alzheimer's disease:the “LEARn” model. Biogerontology 9:375–379.
95. P.J.Landrigan, B.Sonawane, R.N.Butler, L.Trasande, R.Callan, D.Droller. 2005. Early environmental origins of neurodegenerative disease in later life. Environ Health Perspect 113: 1230–1233.
96. H.J.Lee, S.M.Baek, D.H.Ho, J.E.Suk, E.D.Cho, S.J.Lee. 2011. Dopamine promotes formation and secretion of non- fibrillar alpha-synuclein oligomers. Exp Mol Med 43: 216–222.
97. K.Lehmann, M.Butz, G.Teuchert-Noodt. 2005. Offer and demand:proliferation and survival of neurons in the dentate gyrus. Eur J Neurosci 21:3205–3216.
98. S.L.Leong, R.Cappai, K.J.Barnham, C.L.Pham. 2009. Modulation of alpha-synuclein aggregation by dopamine:a review. Neurochem Res 34:1838–1846.
99. S.Lesné, C.Ali, C.Gabriel, N.Croci, E.T.MacKenzie, C.G.Glabe,. 2005. NMDA receptor activation inhibits alpha-secretase and promotes neuronal amyloid-beta production. J Neurosci 25:9367–9377.
100. B.Leuner, E.Gould. 2010. Structural plasticity and hippocampal function. Annu Rev Psychol 61:111–113.
101. C.W.Levenson, D.Morris. 2011. Zinc and neurogenesis:making new neurons from development to adulthood. Adv Nutr 2: 96–100.
102. F.H.Lewy. 1912. Paralysis agitans. 1. Pathologische Anatomie. In:M.Lewandowsky, editor. Handbuch der Neurologie. Berlin:Julius Springer. p. 920–933.
103. M.S.Lidow, P.Rakic. 1992. Scheduling of monoaminergic neurotransmitter receptor expression in the primate neocortex during postnatal development. Cereb Cortex 2:401–416.
104. D.Liu, J.Diorio, J.C.Day, D.D.Francis, M.J.Meaney. 2000. Maternal care, hippocampal synaptogenesis and cognitive development in rats. Nat Neurosci 3:799–806.
105. G.Logroscino. 2005. The role of early life environmental risk factors in Parkinson disease:what is the evidence? Environ Health Perspect 113:1234–1238.
106. Q.L.Ma, P.Chan, M.Yoshii, K.Ueda. 2003. Alpha-synuclein aggregation and neurodegenerative diseases. J Alzheimers Dis 5:139–148.
107. J.E.Malberg, L.E.Schechter. 2005. Increasing hippocampal neurogenesis:a novel mechanism for antidepressant drugs. Curr Pharm Des 11:145–155.
108. J.E.Malberg, A.J.Eisch, E.J.Nestler, R.S.Duman. 2000. Chronic antidepressant treatment increases neurogenesis in adult rat hippocampus. J Neurosci 20:9104–9410.
109. N.Mattsson, K.Savman, G.Osterlundh, K.Blennow, H.Zetterberg. 2010. Converging molecular pathways in human neural development and degeneration. Neurosci Res 66: 330–332.
110. G.F.Michel, A.N.Tyler. 2005. Critical period:A history of the transition from questions of when, to what, to how. Dev Psychobiol 46:156–162.
111. R.Miettinen, J.Sirvio, P.Riekkinen Sr, M.P.Laakso, M.Riekkinen, P.RiekkinenJr. 1993. Neocortical, hippocampal and septal parvalbumin- and somatostatin-containing neurons in young and aged rats:correlation with passive avoidance and water maze performance. Neuroscience 53:367–378.
112. D.B.Miller, J.P.O'Callaghan. 2008. Do early-life insults contribute to the late-life development of Parkinson and Alzheimer diseases? Metabolism 57:44–49.
113. C.Mirescu, E.Gould. 2006. Stress and adult neurogenesis. Hippocampus 16:233–238.
114. V.M.Moceri, W.A.Kukull, I.Emanuel, B.G.van, E.B.Larson. 2000. Early-life risk factors and the development of Alzheimer's disease. Neurology 54:415–420.
115. W.Y.Mok, L.W.Chu, C.P.Chung, N.Y.Chan, S.L.Hui. 2004. The relationship between non-cognitive symptoms and functional impairment in Alzheimer's disease. Int J Geriatr Psychiatry 19:1040–1046.
116. L.A.Mongiat, A.F.Schinder. 2011. Adult neurogenesis and the plasticity of the dentate gyrus network. Eur J Neurosci 33: 1055–1061.
117. E.Monroy, E.Hernandez-Torres, G.Flores. 2010. Maternal separation disrupts dendritic morphology of neurons in prefrontal cortex, hippocampus, and nucleus accumbens in male rat offspring. J Chem Neuroanat 40:93–101.
118. J.H.Morrison, M.G.Baxter. 2012. The ageing cortical synapse:hallmarks and implications for cognitive decline. Nat Rev Neurosci 13:240–250.
119. W.Muangpaisan, A.Mathews, H.Hori, D.Seidel. 2011. A systematic review of the worldwide prevalence and incidence of Parkinson's disease. J Med Assoc Thai 94:749–755.
120. J.Neddens, K.Brandenburg, G.Teuchert-Noodt, R.R.Dawirs. 2001. Differential environment alters ontogeny of dopamine innervation of the orbital prefrontal cortex in gerbils. J Neurosci Res 63:209–213.
121. J.Neddens, F.Bagorda, A.Busche, S.Horstmann, G.H.Moll, R.R.Dawirs, G.Teuchert-Noodt. 2003. Epigenetic factors differentially influence postnatal maturation of serotonin (5-HT) innervation in cerebral cortex of gerbils:interaction of rearing conditions and early methamphetamine challenge. Brain Res Dev Brain Res 146:119–130.
122. P.G.Nelson. 2005. Activity-dependent synapse modulation and the pathogenesis of Alzheimer disease. Curr Alzheimer Res 2:497–506.
123. J.Neufeld, G.Teuchert-Noodt, K.Grafen, Y.Winter, A.V.Witte. 2009. Synapse plasticity in motor, sensory, and limbo-prefrontal cortex areas as measured by degrading axon terminals in an environment model of gerbils (Meriones unguiculatus). Neural Plast 2009:281561.
124. M.Niwa, Y.Matsumoto, A.Mouri, N.Ozaki, T.Nabeshima. 2011. Vulnerability in early life to changes in the rearing environment plays a crucial role in the aetiopathology of psychiatric disorders. Int J Neuropsychopharmacol 14: 459–477.
125. M.Ota, F.Yasuno, H.Ito, C.Seki, S.Nozaki, T.Asada, T.Suhara. 2006. Age-related decline of dopamine synthesis in the living human brain measured by positron emission tomography with L-[beta-11C]DOPA. Life Sci 79:730–736.
126. R.H.Parri, T.K.Dineley. 2010. Nicotinic acetylcholine receptor interaction with beta-amyloid:molecular, cellular, and physiological consequences. Curr Alzheimer Res 7:27–39.
127. T.L.Patterson, L.W.Smith, T.L.Smith, J.Yager, I.Grant. 1992. Symptoms of illness in late adulthood are related to childhood social deprivation and misfortune in men but not in women. J Behav Med 15:113–125.
128. S.Petry, J.L.Cummings, M.A.Hill, J.Shapira. 1988. Personality alterations in dementia of the Alzheimer type. Arch Neurol 45:1187–1190.
129. B.Picconi, G.Piccoli, P.Calabresi. 2012. Synaptic dysfunction in Parkinson's disease. Adv Exp Med Biol 970:553–572.
130. C.Power, C.Thomas, L.Li, C.Hertzman. 2012. Childhood psychosocial adversity and adult cortisol patterns. Br J Psychiatry 201:199–206.
131. H.Przuntek, T.Müller, P.Riederer. 2004. Diagnostic staging of Parkinson's disease:conceptual aspects. J Neural Transm 111:201–216.
132. D.Purves, W.D.Snider, J.T.Voyvodic. 1988. Trophic regulation of nerve cell morphology and innervation in the autonomic nervous system. Nature 336:123–128.
133. D.Puzzo, L.Privitera, M.Fa’, A.Staniszewski, G.Hashimoto, F.Aziz,. 2011. Endogenous amyloid-beta is necessary for hippocampal synaptic plasticity and memory. Ann Neurol 69:819–830.
134. A.D.Randall, J.Witton, C.Booth, A.Hynes-Allen, J.T.Brown. 2010. The functional neurophysiology of the amyloid precursor protein (APP) processing pathway. Neuropharmacology 59:243–267.
135. B.Ravina, R.Camicioli, P.G.Como, L.Marsh, J.Jankovic, D.Weintraub, J.Elm. 2007. The impact of depressive symptoms in early Parkinson disease. Neurology 69:342–347.
136. U.Rüb, K.Del Tredici, C.Schultz, E.Ghebremedhin, R.A.de Vos, E.Jansen Steur, H.Braak. 2002. Parkinson's disease:the thalamic components of the limbic loop are severely impaired by alpha-synuclein immunopositive inclusion body pathology. Neurobiol Aging 23:245–254.
137. E.H.Rubin, D.A.Kinscherf. 1989. Psychopathology of very mild dementia of the Alzheimer type. Am J Psychiatry 146:1017–1021.
138. A.Rubio, M.Pérez, J.Avila. 2006. Acetylcholine receptors and tau phosphorylation. Curr Mol Med 6:423–428.
139. T.Ruediger, J.Bolz. 2007. Neurotransmitters and the development of neuronal circuits. Adv Exp Med Biol 621:104–115.
140. B.R.Rund. 2009. Is schizophrenia a neurodegenerative disorder? Nord J Psychiatry 63:196–201.
141. A.T.Schaefers. 2012. Rearing conditions and domestication background determine regulation of hippocampal cell proliferation and survival in adulthood – laboratory CD1 and C57Bl/6 mice versus wild house mice. Neuroscience 228:120–127.
142. A.T.Schaefers, K.Grafen, G.Teuchert-Noodt, Y.Winter. 2010. Synaptic remodeling in the dentate gyrus, CA3, CA1, subiculum, and entorhinal cortex of mice:effects of deprived rearing and voluntary running. Neural Plast 2010:870573.
143. S.Scheff. 2003. Reactive synaptogenesis in aging and Alzheimer's disease:lessons learned in the Cotman laboratory. Neurochem Res 28:1625–1630.
144. P.Seeman, N.H.Bzowej, H.C.Guan, C.Bergeron, L.E.Becker, G.P.Reynolds,. 1987. Human brain dopamine receptors in children and aging adults. Synapse 1:399–404.
145. J.Sian-Hülsmann, S.Mandel, M.B.Youdim, P.Riederer. 2011. The relevance of iron in the pathogenesis of Parkinson's disease. J Neurochem 118:939–957.
146. A.Stéphan, S.Davis, H.Salin, S.Dumas, J.Mallet, S.Laroche. 2002. Age-dependent differential regulation of genes encoding APP and alpha-synuclein in hippocampal synaptic plasticity. Hippocampus 12:55–62.
147. J.T.Stieler, T.Bullmann, F.Kohl, O.Toien, M.K.Bruckner, W.Hartig,. 2011. The physiological link between metabolic rate depression and tau phosphorylation in mammalian hibernation. PLoS One 6:e14530.
148. S.W.Suh, S.J.Won, A.M.Hamby, B.H.Yoo, Y.Fan, C.T.Sheline,. 2009. Decreased brain zinc availability reduces hippocampal neurogenesis in mice and rats. J Cereb Blood Flow Metab 29:1579–1588.
149. D.Tampellini, N.Rahman, E.F.Gallo, Z.Huang, M.Dumont, E.Capetillo-Zarate,. 2009. Synaptic activity reduces intraneuronal Abeta, promotes APP transport to synapses, and protects against Abeta-related synaptic alterations. J Neurosci 29:9704–9713.
150. M.H.Teicher, C.M.Anderson, A.Polcari. 2012. Childhood maltreatment is associated with reduced volume in the hippocampal subfields CA3, dentate gyrus, and subiculum. Proc Natl Acad Sci USA 109:E563–E572.
151. G.Teuchert-Noodt. 2000. Neuronal degeneration and reorgani zation:a mutual principle in pathological and healthy inter actions of limbic and prefrontal circuits. J Neural Transm 60:315–333.
152. G.Teuchert-Noodt, R.R.Dawirs. 1991. Age-related toxicity in prefrontal cortex and caudate-putamen complex of gerbils (Meriones unguiculatus) after a single dose of methamphetamine. Neuropharmacology 30:733–743.
153. G.Teuchert-Noodt, R.R.Dawirs, K.Hildebrandt. 2000. Adult treatment with methamphetamine transiently decreases dentate granule cell proliferation in the gerbil hippocampus. J Neural Transm 107:133–143.
154. D.R.Thal, T.K.Del, H.Braak. 2004. Neurodegeneration in normal brain aging and disease. Sci Aging Knowledge Environ 2004:e26.
155. M.S.C.Thomas, M.H.Johnson. 2008. New advances in understanding sensitive periods in brain development. Curr Dir Psychol Sci 17:1–5.
156. P.Tiraboschi, L.A.Hansen, L.J.Thal, J.Corey-Bloom. 2004. The importance of neuritic plaques and tangles to the development and evolution of AD. Neurology 62:1984–1989.
157. J.T.Trachtenberg, B.E.Chen, G.W.Knott, G.Feng, J.R.Sanes, E.Welker, K.Svoboda. 2002. Long-term in vivo imaging of experience-dependent synaptic plasticity in adult cortex. Nature 420:788–794.
158. P.V.Tran, E.S.Carlson, S.J.Fretham, M.K.Georgieff. 2008. Early-life iron deficiency anemia alters neurotrophic factor expression and hippocampal neuron differentiation in male rats. J Nutr 138:2495–5201.
159. P.V.Tran, S.J.Fretham, J.Wobken, B.S.Miller, M.K.Georgieff. 2012. Gestational-neonatal iron deficiency suppresses and iron treatment reactivates IGF signaling in developing rat hippocampus. Am J Physiol Endocrinol Metab 302:E316–324.
160. P.R.Turner, K.O'Connor, W.P.Tate, W.C.Abraham. 2003. Roles of amyloid precursor protein and its fragments in regulating neural activity, plasticity and memory. Prog Neurobiol 70:1–32.
161. G.Turrigiano. 2012. Homeostatic synaptic plasticity:local and global mechanisms for stabilizing neuronal function. Cold Spring Harbor Perspect Biol 4:a005736.
162. G.G.Turrigiano, S.B.Nelson. 2000. Hebb and homeostasis in neuronal plasticity. Curr Opin Neurobiol 10:358–364.
163. V.N.Uversky. 2008. Alpha-synuclein misfolding and neurode generative diseases. Curr Protein Pept Sci 9:507–540.
164. V.N.Uversky, J.Li, A.L.Fink. 2001a. Pesticides directly accelerate the rate of alpha-synuclein fibril formation:a possible factor in Parkinson's disease. FEBS Lett 500:105–108.
165. V.N.Uversky, J.Li, A.L.Fink. 2001b. Metal-triggered structural transformations, aggregation, and fibrillation of human alpha-synuclein. A possible molecular NK between Parkinson's disease and heavy metal exposure.J Biol Chem 276: 44284–44296.
166. H.van Praag, G.Kempermann, F.H.Gage. 1999. Running increases cell proliferation and neurogenesis in the adult mouse dentate gyrus. Nat Neurosci 2:266–270.
167. T.Verina, C.A.Rohde, T.R.Guilarte. 2007. Environmental lead exposure during early life alters granule cell neurogenesis and morphology in the hippocampus of young adult rats. Neuroscience 145:1037–1047.
168. L.Wang, T.Ohishi, A.Shiraki, R.Morita, H.Akane, Y.Ikarashi,. 2012. Developmental exposure to manganese chloride induces sustained aberration of neurogenesis in the hippocampal dentate gyrus of mice. Toxicol Sci 127:508–521.
169. R.S.Wilson, C.F.Mendes de Leon, L.L.Barnes, J.A.Schneider, J.L.Bienias, D.A.Evans, D.A.Bennett. 2002. Participation in cognitively stimulating activities and risk of incident Alzheimer disease. J Am Med Assoc 287:742–748.
170. K.T.Winterfeld, G.Teuchert-Noodt, R.R.Dawirs. 1998. Social environment alters both ontogeny of dopamine innervation of the medial prefrontal cortex and maturation of working memory in gerbils (Meriones unguiculatus). J Neurosci Res 52:201–209.
171. K.Wirdefeldt, H.O.Adami, P.Cole, D.Trichopoulos, J.Mandel. 2011. Epidemiology and etiology of Parkinson's disease:a review of the evidence. Eur J Epidemiol 26:S1–58.
172. A.V.Witte, S.Brummelte, G.Teuchert-Noodt. 2007a. Developmental pattern changes of prefrontal efferents in the juvenile gerbil (Meriones unguiculatus). J Neural Transm 114:1377–1393.
173. A.V.Witte, F.Bagorda, G.Teuchert-Noodt, K.Lehmann. 2007b. Contralateral prefrontal projections in gerbils mature abnormally after early methamphetamine trauma and isolated rearing. J Neural Transm 114:285–288.
174. J.R.Wolff. 1981. Evidence for a dual role of GABA as a synaptic transmitter and a promoter of synaptogenesis. Adv Biochem Psychopharmacol 29:459–465.
175. J.R.Wolff, M.Missler. 1992. Synaptic reorganization in developing and adult nervous systems. Ann Anat 174: 393–403.
176. J.R.Wolff, G.P.Wagner. 1983. Selforganization in synaptogenesis:interaction between theformation of excitatory and inhibitory synapses. In:E.Basr, H.Flohr, H.Haken, A.J.Mandell, editors. Synergetics of the brain. Berlin, Heidelberg, New York, Tokyo:Springer Verlag. p. 50–59.
177. J.R.Wolff, M.Leutgeb, M.Holzgraefe, G.Teuchert. 1989. Synaptic remodelling during primary and reactive synaptogenesis. In:H.Rahmann, editor. Fundamentals of memory formation:neuronal plasticity and brain function. Stuttgart, New York:Gustav Fischer Verlag. p. 68–82.
178. X.Wu, Y.Fu, G.Knott, J.Lu, C.G.Di, Z.J.Huang. 2012. GABA signaling promotes synapse elimination and axon pruning in developing cortical inhibitory interneurons. J Neurosci 32: 331–343.
179. Q.Xu, Y.Park, X.Huang, A.Hollenbeck, A.Blair, A.Schatzkin, H.Chen. 2010. Physical activities and future risk of Parkinson disease. Neurology 75:341–348.
180. S.Yu, K.Uéda, P.Chan. 2005. Alpha-synuclein and dopamine metabolism. Mol Neurobiol 31:243–254.
181. T.A.Zesiewicz, K.L.Sullivan, R.A.Hauser. 2006. Nonmotor symptoms of Parkinson's disease. Expert Rev Neurother 6:1811–1822.